Skip to content

Early response to Ukrainian refugees enabled continuity of HIV care, but longer-term issues must be addressed as war drags on

Dr Justyna Kowalska at AIDS 2022. Photo©Jordi Ruiz Cirera/IAS

Second-line treatment nearly nine times more expensive than first-line in upper-middle income countries

Dr Deepak Mattur at AIDS 2022.

Injectable PrEP can only cost a little more than oral PrEP if it is to be cost-effective, South African study finds

Dr Gesine Meyer-Rath at AIDS 2022.

Just six injections a year can prevent HIV: here’s what it will take for the world to afford them

Sibongile Tshabalala, Chairperson of South Africa’s Treatment Action Campaign, leading the protest over lack of access to injectable PrEP at AIDS 2022. Photo©Jordi Ruiz Cirera/IAS

ViiV Healthcare to allow 90 countries to access generic versions of HIV prevention shot

Deborah Waterhouse of ViiV Healthcare and Charles Gore of the Medicines Patent Pool announce the agreement at AIDS 2022

Community monitoring uncovers gaps in HIV and hepatitis services in Indian state hard-hit by HIV, sparks reforms

People living with HIV protesting outside the office of the National AIDS Control Organization in Delhi last week. Their sit-in, demanding an end to stockouts of dolutegravir and paediatric formulations, is ongoing. Photo: Bobby Ramakant.

After four months of war, challenges remain for displaced Ukrainians living with HIV

Iryna Mylinska/Shutterstock.com

South Africa could be among the last to rollout child-friendly dolutegravir

Dispersible antiretrovirals. Image: Drugs for Neglected Diseases initiative.

COVID-19 pandemic restrictions did not harm HIV care outcomes in Uganda

Dr Jonathan Izudi presenting at INTEREST 2022. Image by Edith Magak.